AstraZeneca exceeds sales and profits forecast amid coronavirus, outlook unchanged
AstraZeneca exceeds sales and profits forecast amid coronavirus, outlook unchanged

Drugmaker AstraZeneca topped second-quarter sales and profit expectations on Thursday and stood by its 2020 forecasts, helped by strong sales in lockdowns of a diverse line-up, which now includes a potential coronavirus vaccine.